Immune checkpoint inhibitors have changed the future of cancer care. These powerful treatments use the body’s own immune ...

A study led by UCLA has discovered that JAK inhibitors could potentially prevent or reverse immune-related diabetes triggered ...

A team of researchers has identified a potential new strategy to prevent, or even reverse, immune checkpoint ...

A team of researchers at the UCLA Health Jonsson Comprehensive Cancer Center has identified a potential new strategy to ...

Interleukin-2 (IL-2) inhibitors are immunosuppressive agents that block the activity of IL-2, a cytokine involved in the activation and proliferation ...

A team of researchers at the UCLA Health Jonsson Comprehensive Cancer Center has identified a potential new strategy to prevent, and even reverse, immune checkpoint inhibitor–induced type 1 diabetes, ...

Researchers are working to launch a first-in-human clinical trial to test the approach in patients with cancer who develop ...

Global Phase 2 clinical trial, VENTURE, to evaluate the efficacy and safety of verekitug administered every 12 or 24 weeks in moderate-to-severe COPD – ...

This naturally derived compound activates the PI3K/AKT/mTOR signaling pathway in oligodendrocytes, promoting robust remyelination and restoring function in demyelination models.

Promising Psoriasis Pipeline Therapies such as Hypericin, EDP1815, Cetaphil, AX-158, HAT1 topical solution, Calcipotriol, ARQ ...